Balloon Valvuloplasty Device Market Introduction
Balloon valvuloplasty is a common method to treat valve stenosis. Stenosis is the contraction of an opening such as the heart valve. Balloon valvuloplasty, also known as valvuloplasty or balloon valvotomy, is a procedure to repair the heart valve that has a narrowed opening. Balloon valvuloplasty improves blood flow through the valve and treats symptoms.
Read Report Overview – https://www.transparencymarketresearch.com/balloon-valvuloplasty-device-market.html
During valvuloplasty, a thin, long tube known as catheter with a balloon on the tip is inserted into the artery of the patient’s arm or groin. It is then guided into the narrowed valve of the heart using the x-ray machine. The balloon is inflated, which enlarges the opening of the valve and separates the leaflets. The balloon is then deflated and both, the balloon and the catheter, are removed.
Global Balloon Valvuloplasty Device Market- Competitive Landscape
Boston Scientific Corporation
Founded in 1979, Boston Scientific Corporation is headquartered in Marlborough, the U.S. The company develops, manufactures, and markets medical devices used in an extensive range of interventional procedures worldwide. The company is among the leading providers of minimally invasive devices used for the treatment and diagnosis of gastrointestinal diseases. Moreover, it holds a leading position in the spinal cord stimulation devices sector in the U.S. Boston Scientific Corporation has production plants in 12 countries and offices in approximately 40 countries across the globe.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72321
Terumo Corporation
Established in 1921, Terumo Corporation is headquartered in Tokyo, Japan. It is a leading player in the fields of minimally invasive entry site management, lesion access, and interventional technologies. Terumo Corporation operates through a strong network of subsidiaries located in the U.K., Russia, the U.S., Europe, and China. Terumo Corporation operates through three major business segments: Cardiac & Vascular Company, General Hospital Company, and Blood Management Company.
Edwards Lifesciences
Incorporated in 1958, Edwards Lifesciences is headquartered in California, the U.S. It is a medical equipment company specializing in manufacturing hemodynamic monitoring devices and artificial heart valves. The company partners with clinicians to develop advanced technologies in the fields of critical care monitoring and structural heart disease to help patients. The company manufactures products in several global locations, including Puerto Rico, the U.S., the Dominican Republic, and Singapore.
Request for Analysis of COVID-19 Impact on Balloon Valvuloplasty Device Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72321
Global Balloon Valvuloplasty Device Market Dynamics
Increase in Number of Heart Related Conditions to Drive Global Balloon Valvuloplasty Device Market
Rise in the number of heart related conditions across the globe is a key factor driving the balloon valvuloplasty device market. According to the European Society of Cardiology, prevalence and incidences of rheumatic heart disease (RHD) differ significantly among regions and age groups.
The global prevalence of rheumatic heart disease is approximately 1 per 1,000 in children aged between 5 years and 14 years. Additionally, the World Health Organization states that the rheumatic heart disease mostly affects children in developing countries. Worldwide, approximately 2% of deaths that occur due to cardiovascular diseases are related to RHD.
Pre Book Balloon Valvuloplasty Device Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=72321<ype=S
Asia Pacific is Rapidly Expanding Region of Balloon Valvuloplasty Devices
The balloon valvuloplasty device market in Asia Pacific is expected to expand at a faster rate during the forecast period due to factors such as increase in disposable income of consumers, rise in prevalence of heart valve diseases, and improvement in the health care infrastructure. However, North America is expected to dominate the global balloon valvuloplasty device market during the forecast period owing to high number of patients afflicted with cardiovascular diseases and availability of well-established reimbursement policies in countries such as the U.S.
More Trending Reports by Transparency Market Research –
Dental Biomaterials Market: https://www.biospace.com/article/dental-biomaterials-market-increase-in-dental-tourism-in-developing-countries-is-expected-to-boost-the-market/
Laboratory Gas Generators Market: https://www.biospace.com/article/laboratory-gas-generators-market-increase-in-the-number-of-contractual-agreements-and-acquisitions-by-manufacturers-is-projected-to-drive-the-global-market/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
